Pfizer Inc (NYSE:PFE) Insider Geno J. Germano unloaded 30,000 shares of the stock on the open market in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $29.68, for a total value of $890,400.00. Following the transaction, the insider now directly owns 263,495 shares of the company’s stock, valued at approximately $7,820,532. Pfizer Inc. (NYSE:PFE) stock performance was 0.17% in last session and finished the day at $29.64. Traded volume was 23.39million shares in the last session and the average volume of the stock remained 30.43million shares. The beta of the stock remained 0.67. Pfizer Inc. (NYSE:PFE) insider ownership is 0.10%.

Drugmaker Merck & Co., Inc. (NYSE:MRK) has a tablet for house dust mite allergies in final patient testing that could hit the market in two or three years, and it’s considering other therapies. France’s Stallergenes SA is testing a tablet for birch tree allergies and, with partner Shionogi & Co. Ltd. in Japan, tablets for allergies to dust mites and Japanese cedar pollen. Britain’s Circassia Ltd. has a cat allergy treatment in final testing and six others in earlier testing. Merck & Co., Inc. (NYSE:MRK) rose 0.03 percent to $57.93 Wednesday on volume of 6.88million shares. The intra-day range of the stock was $57.51 to $58.01. Merck & Co., Inc. (NYSE:MRK) has a market capitalization of $169.71billion.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), the discoverer of the BELVIQ® drug, today announced initiating the dosage of a pivotal Phase 1b clinical trial of its novel APD334 drug. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’s stock on June 03, 2014 reported a increase of 0.67% to the closing price of $6.05. Its fifty two weeks range is $4.05 -$9.05. The total market capitalization recorded $1.33billion. The overall volume in the last trading session was 2.67million shares. In its share capital, ARNA has 319.64million outstanding shares.

Earlier this month, Bayer AG (ADR) (OTCMKTS:BAYRY) of Germany agreed to buy Merck’s consumer care business for $14.2 billion. On Wednesday, shares of Bayer AG (ADR) (OTCMKTS:BAYRY) dropped -0.13% to close the day at $143.57.